Report Id: SNS/HC/2525 | July 2022 | Region: Global | 127 Pages
Report Scope & Overview:
The Blood Grouping Reagents Market Size was valued at USD 1.90 billion in 2022, and expected to reach USD 4.11 billion by 2030, and grow at a CAGR of 10.1% over the forecast period 2023-2030.
Solutions known as blood grouping reagents can be used to distinguish between the ABO, Rhesus, Kell, and MNS blood groups. These distinctions between types of human blood are made based on whether red blood cells' surfaces contain antigens or not. The reagents may have an impact on the test red blood cells' tendency to aggregate and transmit antigen. There is no way to determine the absence of a specific antigen from the test red blood cells via clumping.
MARKET DYNAMICS
DRIVERS
The No. of Blood Donations is Increasing
An Increase in the Number of Emergencies, Trauma Cases, and Road Accidents That Require Blood Transfusions.
Blood group typing in prenatal testing is in greater demand.
Blood group typing is becoming more common in forensic sciences
The Blood Transfusion Market Will Grow as a Result of Strict Regulations
RESTRAINTS
Concern about the effectiveness and precision of test kits
OPPORTUNITIES
Economies in Emergence
Types of Blood Groups Using Molecular Diagnostics
CHALLENGES
The dangers of blood transfusions
IMPACT OF COVID-19
The introduction of the coronavirus had a negative effect on numerous industries worldwide. Due to limitations on production, the suspension of clinical studies, and R&D operations, the healthcare sector also suffered. However, a significant amount of blood grouping reagent items is needed for diagnostic purposes due to the rising number of COVID-19 patients. There is a tremendous global demand for the growing number of assay techniques available to determine whether patients have the coronavirus or not. The market players were under pressure to develop blood grouping reagent items because of the sudden increase in diagnostic procedures. Additionally, the need for blood grouping reagent products is being driven by the increase in RT-PCR and molecular assay testing for disease confirmation.
By Product & Service
Anti-A, Anti-AB, Anti-B, Anti-D (PK 1), Anti-D, Anti-D (PK 2), control reagents, and phenotyping reagents like Anti-C, Anti-E, Anti-c, Anti-e, and Anti-K are only a few examples of consumables used in blood grouping. A variety of businesses, including Merck KGaA, Bio-Rad Laboratories Inc., Novacyt SA, Beckman Coulter, Inc., Grifols SA, and Immucor, Inc., provide consumables to meet market demand.
The ABO grouping, antibody screening, Rh typing, and cross-matching tests utilised by the blood grouping instrument are used to determine blood type. These tools are used to examine blood groups and provide a number of advantages over tests carried out manually by technicians, including a decrease in human error.
By Technique
Blood screening and other mass testing and diagnostic applications have been directly impacted by the accelerating development of molecular biology techniques. The identification of blood groups has been effectively accomplished using PCR and microarray techniques. The antigen type of donor RBCs for transfusion and antibody identification reagent panels can be predicted using PCR-based assays.
An analytical technique used for blood grouping is known as an assay-based technique. Blood grouping is done using bead-based technology, such as the Luminex technique, and solid-phase assays like ELISA. Reagent antigens or antibodies attached to a surface are used in solid-phase tests (usually a microplate). Solid-phase assays are utilised by a number of automated analyzers for blood grouping.
A thorough blood-group variation profile is provided using massively parallel sequencing techniques. The development of this approach is hampered by a scarcity of skilled workers since it requires labor-intensive data analysis by blood-group genetics specialists.
A diagnostic method for identifying antibodies in serum is known as serology, which involves looking for antigens on the outside of blood cells. The increased demand for blood products for many different antigens cannot be met by this approach due to some of its drawbacks. The serology section is further divided into the following sub-segments: gel technique, erythrocytes magnetized technology (EMT), solid-phase red-cell adhesion (SPRCA), glass tube, glass slide, cassette/kits, and others.
By Test Type
The type of antigens that are found on RBCs are known as their phenotype. The 'type and screen' establishes the patient's ABO-Rh while screening for the presence of the most frequently discovered surprising antibodies. All patients who require transfusions undergo it. However, it is also possible to execute an extended antigen phenotype.
To determine whether an antibody to a red cell antigen has been generated, antibody screening is carried out. Antibody screening is done to look for antibodies in blood transfusion recipients, expectant mothers, those who might be having blood and plasma donors, and transfusion reactions.
To make sure the donor blood is compatible before a blood transfusion, crossmatching tests, which are among the most crucial serological testing, are carried out. The recipient's plasma is combined with donor blood cells in this procedure, and agglutination reactions are then looked for.
Analyzing the presence or absence of a specific antibody (qualitative) or the quantity of antibody present is a necessary step in the identification of an antibody (quantitative). Antibody identification testing is used for a variety of purposes, such as documenting exposure to an infectious or foreign agent, assessing immune status against a specific microorganism, diagnosing an autoimmune condition, determining the cause of a transfusion reaction or the rejection of an organ transplant, identifying an allergy, and tracking the progression of an infection or autoimmune process.
There are two blood tests used in immunohematology, both of which are known as Coombs tests or antiglobulin tests. The Coombs tests are the direct and indirect ones. A direct Coombs test is used to determine whether an individual's internal red blood cells contain abnormally bound antibodies, which can happen in situations like autoimmune hemolytic anaemia, infant hemolytic illness, and transfusion responses. The indirect Coombs test is employed to detect specific blood group antigens as well as screen for antibodies that may result in transfusion reactions.
If clinically significant autoantibodies are discovered in a patient, antigen typing is carried out. It is done for the corresponding antigens to determine whether the antibodies are alloantibodies or autoantibodies.
By End User
To learn one's blood type, a person often goes to a clinic or hospital. A doctor or nurse takes a blood sample in a clinic or hospital and sends it to a lab for analysis. Hospitals often have associated laboratories, and the staff working in these labs is employed by the hospital. These labs carry out both inpatient and outpatient laboratory testing. The main duties of blood banks are to collect, process, test, store, and distribute whole blood and blood products. Blood is donated annually in the US, says the American National Red Cross. Once blood has been donated, a number of conventional tests, including ABO grouping and Rh type, are performed in the lab. Clinical laboratories are independent businesses or organisations that test goods and materials in accordance with specifications. Third-party testing refers to testing conducted by unbiased laboratories. These clinical laboratories offer cutting-edge testing services and may offer hospitals and clinics without the necessary facilities a more affordable option.
COMPETITIVE LANDSCAPE
Some of the major key players are as follows: Beckman Coulter, Inc, Diagast SAS, Bio-Rad Laboratories, Inc, DAY medical SA, Haemo kinesis Pty Ltd, MTC Med. Produkte GmbH, Novacyt Group, Ortho Clinical Diagnostics, Merck KGaA, Yuvraj Biobiz Incubator India Pvt, Rapid Labs Ltd.
MARKET SEGMENTS:
By Product
Consumables
Instruments
By Technique
PCR-based and Microarray Technique
Assay-Based Techniques
Massively Parallel Sequencing Techniques
Serology
Other Techniques
By Test Type
Blood Group and Phenotype
Antibody Screening
Cross-matching Tests
Antibody Identification
Coombs Tests
Antigen Typing
By End User
Hospitals
Blood Banks
Clinical Laboratories
REGIONAL ANALYSIS
Given the prevalence of various chronic conditions that increase the need for blood transfusions as well as organ transplants, as well as the strong foundation of some of the most affluent competitors, North America now leads the world in the blood grouping business. Continual market growth may also be ensured by technological advancements in the healthcare field and the rising public awareness level. A large number of the manufacturers in the area are introducing new test kits and other items, or they concentrate on working with other businesses to improve the cash flow channel while also outsourcing the production process. Additionally, substantial investments in extended research projects and a team effort to advance the technology for blood grouping could boost the market position in the ensuing years. Additionally, substantial investments in extended research projects and a team effort to advance the technology for blood grouping could boost the market position in the ensuing years.
In the coming years, the blood grouping reagents market in the Asia Pacific region is anticipated to grow at the fastest rate. The increased number of injuries from trauma or accidents may be one of the main causes of the region's large market growth. Increased demand is further fueled by increased usage of blood banking services, an increase in government programmes, and growing public awareness of blood donation.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Report Attributes | Details |
---|---|
Market Size in 2022 | US$ 1.90 Billion |
Market Size by 2030 | US$ 4.11 Billion |
CAGR | CAGR of 10.1% From 2023 to 2030 |
Base Year | 2022 |
Forecast Period | 2023-2030 |
Historical Data | 2020-2021 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | • By Product (Consumables, Instruments) • By Technique (PCR-based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, Other Techniques) • By Test Type (Blood Group and Phenotype, Antibody Screening, Cross-matching Tests, Antibody Identification, Coombs Tests, Antigen Typing) • By End User (Hospitals, Blood Banks, Clinical Laboratories) |
Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
Company Profiles | Beckman Coulter, Inc, Diagast SAS, Bio-Rad Laboratories, Inc, DAY medical SA, Haemo kinesis Pty Ltd, MTC Med. Produkte GmbH, Novacyt Group, Ortho Clinical Diagnostics, Merck KGaA, Yuvraj Biobiz Incubator India Pvt, Rapid Labs Ltd. |
Key Drivers | • The No. of Blood Donations is Increasing • An Increase in the Number of Emergencies, Trauma Cases, and Road Accidents That Require Blood Transfusions. |
RESTRAINTS | • Concern about the effectiveness and precision of test kits. |
Frequently Asked Questions (FAQ) :
Ans. Blood Grouping Reagents Market Size was valued at USD 1738.2 million in 2021.
Ans. Economies in Emergence, and Types of Blood Groups Using Molecular Diagnostics are the key drivers of the Blood Grouping Reagents market
Ans. North America now leads the world in the blood grouping business. Continual market growth may also be ensured by technological advancements in the healthcare field and the rising public awareness level.
Ans. Manufacturer and service provider, research institutes, university and private libraries, suppliers and distributers.
Ans. Blood Grouping Reagents market is divided in four segments and they are By Product, By Technique, By Test Type, and By End User
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Blood Grouping Reagents Market Segmentation, By Product
8.1 Consumables
8.2 Instruments
9. Blood Grouping Reagents Market Segmentation, By Technique
9.1 PCR-based and Microarray Technique
9.2 Assay-Based Techniques
9.3 Massively Parallel Sequencing Techniques
9.4 Serology
9.5 Other Techniques
10. Blood Grouping Reagents Market Segmentation, By Test Type
10.1 Blood Group and Phenotype
10.2 Antibody Screening
10.3 Cross-matching Tests
10.4 Antibody Identification
10.5 Coombs Tests
10.6 Antigen Typing
11. Blood Grouping Reagents Market Segmentation, By End User
11.1 Hospitals
11.2 Blood Banks
11.3 Clinical Laboratories
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13.Company Profiles
13.1 Beckman Coulter, Inc.
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Diagast SAS
13.3 Bio-Rad Laboratories, Inc
13.4 DAY medical SA
13.5 Haemo kinesis Pty Ltd
13.6 MTC Med. Produkte GmbH
13.7 Novacyt Group
13.8 Ortho Clinical Diagnostics
13.9 Merck KGaA
13.10 Yuvraj Biobiz Incubator India Pvt
14.Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share analysis
14.3 Recent Developments
15.Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.
Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.